Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Intellikine (therapies for autoimmune diseases, cancer, and inflammation) raised $28.5mm through its second round of venture financing. Novartis Bioventures (which gets a seat on the company's board) led and was joined by new investors US Venture Partners, Biogen Idec, and FinTech Global Capital. Series A backers Abingworth, CMEA Capital, and Sofinnova Ventures also participated. The company could bring in an additional $22.5mm based on the achievement of certain milestones.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?